Your browser doesn't support javascript.
loading
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells.
Meng, Xiangbo; Liu, Xiwei; Guo, Xingdong; Jiang, Shutan; Chen, Tingting; Hu, Zhiqiang; Liu, Haifeng; Bai, Yibing; Xue, Manman; Hu, Ronggui; Sun, Shao-Cong; Liu, Xiaolong; Zhou, Penghui; Huang, Xiaowu; Wei, Lai; Yang, Wei; Xu, Chenqi.
  • Meng X; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Liu X; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Guo X; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Jiang S; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Chen T; State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
  • Hu Z; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu H; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China.
  • Bai Y; State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Xue M; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Hu R; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Sun SC; State Key Laboratory of Molecular Biology, Shanghai Science Research Center, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Liu X; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhou P; State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Huang X; Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wei L; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yang W; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China.
  • Xu C; State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Nature ; 564(7734): 130-135, 2018 12.
Article en En | MEDLINE | ID: mdl-30487606

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Proteínas F-Box / Ubiquitinación / Receptor de Muerte Celular Programada 1 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Proteínas F-Box / Ubiquitinación / Receptor de Muerte Celular Programada 1 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article